Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...
Mounjaro, the brand name for tirzepatide could be available to nearly 250,000 people on the NHS. | Sandy Huffaker for The Washington Post via Getty Images Speaking about the plans, Dr Sam Roberts ...
The FDA has agreed to revisit its decision to prevent compounders from selling versions of Eli Lilly's diabetes and weight ...
The FDA has decided to reconsider its previous decision that barred drug compounders from selling their versions of Eli Lilly ...
An image of a chain link ... which later won FDA approval for weight loss in 2023 under the brand name Zepbound. A similar version of this drug, called Mounjaro, has been available to people ...